Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy?
The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Multiple sclerosis afflicts more than 1 million individuals worldwide and is widely considered to be an autoimmune disease. Traditionally, CD4(+) T helper cells have almost exclusively been held responsible for its immunopathogenesis, partly because certain MHC class II alleles clearly predispose for developing multiple sclerosis and also, because of their importance in inducing experimental autoimmune encephalomyelitis (EAE), the animal model for multiple sclerosis. However, several strategies that target CD4(+) T cells beneficially in EAE have failed to ameliorate disease activity in multiple sclerosis, and some have even triggered exacerbations. Recently, the potential importance of CD8(+) T cells has begun to emerge. Physiologically, CD8(+) T cells are essential for detecting and eliminating abnormal cells, whether infected or neoplastic. In multiple sclerosis, genetic associations with MHC class I alleles have now been established, and CD8(+) as well as CD4(+) T cells have been found to invade and clonally expand in inflammatory central nervous system plaques. Recent animal models induced by CD8(+) T cells show interesting similarities to multiple sclerosis, in particular, in lesion distribution (more inflammation in the brain relative to the spinal cord), although not all of the features of the human disease are recapitulated. Here we outline the arguments for a possible role for CD8(+) T cells, a lymphocyte subset that has long been underrated in multiple sclerosis and should now be considered in new therapeutic approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669 · cited 3×
“In contrast to CD4 + regulatory T cells which are now relatively well characterized in their expression of CD25 and Foxp3 (Sakaguchi, 2005) and which have been reported to show a decrease in their function from peripheral blood of patients with multiple sclerosis as compared with healthy donors…”
InfluentialImmunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Axonal damage in acute multiple sclerosis lesions
Ferguson, B. (1997) · Brain · doi:10.1093/brain/120.3.393 · Cited by 1,532
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466 · cited 2×
“Furthermore, the perivascular spaces surrounding cerebral and meningeal blood vessels contain a population of myeloid cells, which are thought to play an important role as APCs (Hickey and Kimura, 1988; Weller, 1998).”
Defective CD8 T Cell Memory Following Acute Infection Without CD4 T Cell Help
Sun, J. C., & Bevan, M. J. (2003) · Science · doi:10.1126/science.1083317 · Cited by 1,213 · cited 1×
“…for disease induction and maintenance; in viral infections, we know that they are required early during primary antigen exposure to promote both the differentiation of CD8 + effector cells into long-lived memory cells and their subsequent maintenance (Shedlock and Shen, 2003; Sun and Bevan, 2003).”
Three or more routes for leukocyte migration into the central nervous system
Ransohoff, R. M., Kivisäkk, P., & Kidd, G. (2003) · Nature Reviews Immunology · doi:10.1038/nri1130 · Cited by 1,052 · cited 8×
“However, it has been shown that DCs are present in normal human meninges, choroid plexus and cerebrospinal fluid (CSF) and can be recruited and/or develop into DCs in injured or inflamed brain tissue (Pashenkov et al., 2001; Pashenkov and Link, 2002).”
InfluentialBabbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
Self-citationAcute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898 · cited 1×
“In addition, axonal damage within multiple sclerosis lesions correlates with the number of CD8 + T cells (Bitsch et al., 2000; Kuhlmann et al., 2002) and macrophages/ microglial cells (Ferguson et al., 1997; Trapp et al., 1998; Kornek et al., 2000), but not with other subsets of immune cells, such…”
Cross-Presentation, Dendritic Cells, Tolerance and Immunity
Heath, W. R., & Carbone, F. R. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.47 · Cited by 882 · cited 2×
“Immune complex-forming autoantibodies, high T cell precursor frequencies and the induction of apoptosis in target tissue further enhance the amount of cross-presented self-antigens (Heath and Carbone, 2001; Kita et al., 2002).”
Cited by
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187
Self-citationInteractions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T., Barcellos, L. F., & Alfredsson, L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,185
The Immunopathology of Multiple Sclerosis: An Overview
Lassmann, H., Brück, W., & Lucchinetti, C. F. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00064.x · Cited by 1,182
Autoimmune T cell responses in the central nervous system
Goverman, J. (2009) · Nature Reviews Immunology · doi:10.1038/nri2550 · Cited by 1,030
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017
“Also, we have avoided extensive discussion of CD8+ T cells in EAE/MS because this topic has recently been handled in Friese and Fugger (2005).”
BackgroundInfluentialMultiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
The cellular inflammatory response in human spinal cords after injury
Fleming, J. C., Norenberg, M. D., Ramsay, D. A., Dekaban, G. A., Marcillo, A. E., Saenz, A. D., Pasquale-Styles, M., Dietrich, W. D., & Weaver, L. C. (2006) · Brain · doi:10.1093/brain/awl296 · Cited by 847
Active induction of experimental allergic encephalomyelitis
Stromnes, I. M., & Goverman, J. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.285 · Cited by 573
Choi, I. Y., Piccio, L., Childress, P., Bollman, B., Ghosh, A., Brandhorst, S., Suarez, J., Michalsen, A., Cross, A. H., Morgan, T. E., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.009 · Cited by 505
Pathology of multiple sclerosis and related inflammatory demyelinating diseases
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-52001-2.00002-9 · Cited by 303
The molecular basis of neurodegeneration in multiple sclerosis
Lassmann, H., & van Horssen, J. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.08.004 · Cited by 294
Lifestyle and Environmental Factors in Multiple Sclerosis
Alfredsson, L., & Olsson, T. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a028944 · Cited by 237
“Class I molecules present antigen to CD8+ T cells and they can be cytotoxic, but also convey suppressor functions through production of molecules like transforming growth factor (TGF)-β (for a review on CD8+ T cells in MS, see Friese and Fugger 2005; Friese et al. 2008; Dendrou et al. 2015).”
BackgroundMechanisms of white matter damage in multiple sclerosis
Lassmann, H. (2014) · Glia · doi:10.1002/glia.22597 · Cited by 191
“CD81 T-lymphocytes dominate the inflammatory infiltrates in the MS brain (Friese and Fugger, 2005) and experiments with CD81 T-cells from animals with autoimmune encephalomyelitis induced by active sensitization with myelin oligodendrocyte glycoprotein suggested a pathogenic role in autoimmune…”
BackgroundBerard, J. L., Wolak, K., Fournier, S., & David, S. (2010) · Glia · doi:10.1002/glia.20935 · Cited by 147
“While the role of CD81 T cells in EAE has often been viewed as regulatory (Friese and Fugger, 2005), several studies have shown that CD81 T cells are capable of being encephalitogenic and can induce severe forms of EAE (Huseby et al., 2001; Sun et al., 2001).”
BackgroundChoi, I. Y., Lee, C., & Longo, V. D. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.042 · Cited by 133
Contribution of Astrocyte-Derived IL-15 to CD8 T Cell Effector Functions in Multiple Sclerosis
Saikali, P., Antel, J. P., Pittet, C. L., Newcombe, J., & Arbour, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002188 · Cited by 101
Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers
Wang, T., Lee, M.-H., Johnson, T., Allie, R., Hu, L., Calabresi, P. A., & Nath, A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.0311-10.2010 · Cited by 58
Sen, M. K., Almuslehi, M. S. M., Gyengesi, E., Myers, S. J., Shortland, P. J., Mahns, D. A., & Coorssen, J. R. (2019) · Cells · doi:10.3390/cells8111314 · Cited by 35
Fischer, H. J., Schweingruber, N., Lühder, F., & Reichardt, H. M. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.04.001 · Cited by 34
Almuslehi, M. S. M., Sen, M. K., Shortland, P. J., Mahns, D. A., & Coorssen, J. R. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00043 · Cited by 34
“Notably, the predominance of CD8+ T-cell in the CNS of mice (Study 2) resembles that seen at MS lesion sites where the key steps include recruitment and clonal expansion (Hauser et al., 1986; Friese and Fugger, 2005), with CD8+ outnumbering CD4+ T-cells by 3–10 fold (Booss et al.”
BackgroundEfficient peptide recovery from secreted recombinant MHC-I molecules expressed via mRNA transfection
Lazarus, D., Weinstein-Marom, H., Fishman, S., Yossef, R., Zuri, D., Barnea, E., Admon, A., Margalit, A., & Gross, G. (2015) · Immunology Letters · doi:10.1016/j.imlet.2015.03.008 · Cited by 7
Metadata
- Authors
- Friese, M. A., & Fugger, L.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-06-23
- Volume
- 128
- Issue
- 8
- Pages
- 1747-1763
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W1990062483
- Cited by
- 251
- References
- 25
- FWCI
- 12.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.